ACER ANALİTİK - ÜRÜNLER

MTB (Mycobacterium tuberculosis) Detection Kit

Rapid MDx Solution for TB diagnosis with Proven Performance

FEATURES

40 minutes of turn-around-time using GENECHECKER^® UF-300 and UF-340 system

Simple workflow for minimized user handling with enhanced testing capacity (8 tests/run)

Excellent testing performance assured by high sensitivity and specificity

Assay is designed to detect IS6110 gene and MBP64 gene of Mycobacterium tuberculosis

Compact and affordable solution that suits any application

CONFIGURATION OF TEST CHIP

SMARTCHEK® MTB (Mycobacterium tuberculosis) Detection Kit has been developed to detect IS6110 gene and MBP64 gene of Mycobacterium tuberculosis. The primer pairs and probes for these two target genes are pre-labeled (dehydrated) in the wells of the test chip so that the user won’t need to pipette primers and probes for running the test. Well number 1 is for running negative control and well number 10 is for running positive control. With this test chip configuration, 8 samples can be tested per run.

WORKFLOW

KIT CONTENTS

Item	Quantity / Volume	Description	Storage
Item	Test Chip	Description	Undefined	Individually vacuum packed	Store at below -20℃
Premix	Undefined	Tubes with blue label on the cap
Water	Undefined	Tubes with white label on the cap
5-strip tubes	Undefined	For centrifuging premix and template
Sealing Tape	Undefined	Packed in plastic bag in a row

ORDERING INFORMATION

Cat. No.

Product

Pack Size

9799151600

SMARTCHEK® MTB (Mycobacterium tuberculosis) Detection Kit

200tests/PK

1399100200

GENECHECKER® UF-300 Real-time PCR System

1 SET

1499100100

GENECHECKER® UF-340 Real-time PCR System

1 SET

You can download further information from below section.

SMARTCHEK® MTB Detection Kit

Why is TB diagnosis still being a challenge?

Tuberculosis which is an infectious disease caused by tuberculosis bacteria, usually affects lungs, but can also affect other body organs, such as lymph nodes, kidney, peritoneum, intestine or even skin. According to announcement from WHO, an estimated 10 million people fell ill with tuberculosis and a 1.4 million people died from TB worldwide in 2019. Early diagnosis is one of the key factors for treatment of the disease due to its side effects and additional infections caused by misdiagnosis. As a result, development and applications of tuberculosis assays to assure its high sensitivity and accuracy are still actively ongoing throughout the world.

Better detection assay to enhance your testing efficiency

This assay is containing Mycobacterium tuberculosis specific primer pairs and can diagnose Mycobacterium tuberculosis infection in 40 minutes. This assay uses real-time polymerase chain reaction (PCR) technology and TaqMan^® Probe chemistry to detect target genes. Through PCR process, target-specific sequences are amplified, and target-specific primers and probes combine with a single strand of cDNA and amplified using DNA polymerase enzymes included in the premix formulation. Real-time amplification curves are displayed on the GENECHECKER^® UF-300 / UF-340 real-time PCR platform by the method of monitoring fluorescence signals generated from the reporter dye on 5’ end of the probes after exonuclease activities.